Stockreport

Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Updates

Monopar Therapeutics Inc.  (MNPR) 
PDF Camsirubicin Phase 1b Clinical Trial Anticipated to Start in the U.S. in Q4 2021Validive® Phase 2b/3 VOICE Trial on Track for Reaching Interim Analysis in H1 2022 WILME [Read more]